开放邀请加入儿童质子/光子联盟登记处以标准化儿童放射肿瘤学数据收集
儿童质子/光子联盟登记处(PPCR)是一个纳入接受放疗的儿童患者的综合数据登记平台,截至2019年7月25日已入组2775例,其中62.0%为中枢神经系统肿瘤。该登记处收集详细的健康与治疗数据、DICOM影像及放疗计划,并开展可选的PedsQL生活质量研究,旨在加速基于结局的研究。
要点
- PPCR纳入在美国15家参与机构接受放疗的22岁以下患者,截至2019年7月25日入组2775例。
- 入组患者中62.0%为中枢神经系统肿瘤,最常见为髓母细胞瘤349例、室管膜瘤309例、胶质/星形细胞瘤279例。
- 非中枢神经系统最常见诊断为横纹肌肉瘤284例、尤文肉瘤153例、神经母细胞瘤130例。
核心结论
- PPCR是一个有价值的研究平台,能够回答无数研究问题,最终改善患者照护。
- 邀请美国以外的中心直接参与,或与PPCR合作调整数据收集策略以促进大规模国际研究。
研究设计与样本
- PPCR是一个综合数据登记处,纳入接受放疗的儿童患者,旨在加速基于结局的研究。
- 当前入组标准为在15家美国参与机构之一接受放疗的22岁以下患者。
- 通过REDCap收集疾病表现和治疗暴露的详细健康与治疗数据,并每年随访更新。
- 通过MIM/MIMcloud收集DICOM影像和放疗计划。
- 在10个站点开展可选的患者报告生活质量(PedsQL)研究。
诊断标准与关键数值
- 截至2019年7月25日,自2012年10月开始入组以来共入组2775例参与者。
- 62.0%的患者为中枢神经系统肿瘤,最常见为髓母细胞瘤(n=349)、室管膜瘤(n=309)和胶质/星形细胞瘤(n=279)。
- 非中枢神经系统最常见诊断为横纹肌肉瘤(n=284)、尤文肉瘤(n=153)和神经母细胞瘤(n=130)。
- 大多数参与者为美国居民,18.7%来自其他36个国家。
- 超过685例患者参与PedsQL研究。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The Pediatric Proton/Photon Consortium Registry (PPCR) is a comprehensive data registry composed of pediatric patients treated with radiation. It was established to expedite outcomes-based research. The attributes which allow the PPCR to be a successful collaboration are reviewed.
METHODS AND MATERIALS: Current eligibility criteria are radiotherapy patients < 22 years treated at one of the 15 US participating institutions. Detailed health and treatment data are collected about the disease presentation and treatment exposures, and annually thereafter, in REDCap (Research Electronic Data Capture). DICOM (Digital Imaging and Communications in Medicine) imaging and radiation plans are collected through MIM/MIMcloud. An optional patient-reported quality-of-life (PedsQL) study is administered at 10 sites.
RESULTS: Accrual started October 2012 with 2,775 participants enrolled as of 25 July 2019. Most patients, 62.0%, were treated for central nervous system (CNS) tumors, the most common of which are medulloblastoma (n = 349), ependymoma (n = 309), and glial/astrocytoma tumors (n = 279). The most common non-CNS diagnoses are rhabdomyosarcoma (n = 284), Ewing's sarcoma (n = 153), and neuroblastoma (n = 130). While the majority of participants are US residents, 18.7% come from 36 other countries. Over 685 patients participate in the PedsQL study.
CONCLUSIONS: The PPCR is a valuable research platform capable of answering countless research questions that will ultimately improve patient care. Centers outside of the USA are invited to participate directly or may engage with the PPCR to align data collection strategies to facilitate large-scale international research.
ADVANCES IN KNOWLEDGE: For investigators looking to carry out research in a large pediatric oncology cohort or interested in registry work, this paper provides an updated overview of the PPCR.
引用
- Lawell MP, Indelicato DJ, Paulino AC, et al. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2019. PMID: 31600082. doi:10.1259/bjr.20190673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。